KIDS SHOULD GROW STRONGER.
Their nearsightedness shouldn't.
Coopervision.com Coopervision.com

MiSight® 1 day soft contact lenses are specifically designed for myopia control and are FDA approved* to slow the progression of myopia in children aged 8-12 at the initiation of treatment.1†

Sign up to learn more about MiSight® 1 day:

*By submitting this form, you grant CooperVision, Inc. permission to add your contact information to our database to send you information and communications related to our products and services. The use of personal contact information will be treated in accordance with CooperVision’s Privacy Policy and in accordance with the California Consumer Privacy Act of 2018 (CCPA)

What is myopia?

Myopia is a common eye condition. Its most frequent symptom is nearsightedness, or the inability to see objects clearly at a distance.

The reason objects are blurry in the distance with nearsightedness is because the eye becomes longer as the child grows.

eyechart eyechart
Start managing your child’s myopia today.
approved MiSight® 1 day soft contact lenses are specifically designed for myopia control and are FDA approved* to slow the progression myopia in children aged 8-12 at the initiation of treatment.1†
59% Age-appropriate children wearing MiSight® experienced an average of 59% reduction in myopia progression over three years.1†§
eyehealth Progressive myopia can cause eye health problems later in life.2,3

Learn how your age-appropriate child can have a more brilliant future with MiSight® 1 day.

Learn More

To find a MiSight® certified eye doctor near you, call 1-855-5-Cooper (1-855-526-6737) or email consumercare@coopervision.com

misight box misight box

Indications and Important Safety Information:

RX Only

Results May Vary.

ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information. *Indication: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Warnings: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances MiSight® lenses optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulties with certain visually-demanding tasks. Precautions: Daily wear single use only. Patient should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities. Adverse events: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.

†Compared to a single vision 1 day lens over a 3 year period.

§Children aged 8-12 at the initiation of treatment.

References:

  • 1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567. Optom Vis Sci 2020;97(E-abstract): 200038.
  • 2. Xu L, Wang Y, Wang S, Wang Y Jonas JB. ‘High Myopia and Glaucoma Susceptibility: The Beijing Eye Study. Ophthalmology, 2007;114(2):216-20.
  • 3. Flitcroft DI. The complex interactions of retinal, optical, and environmental factors in myopia aetiology Prog Retin Eye Res. 2012;31(6):622-660.
© 2021 Coopervision. | Part of CooperCompanies
Coopervision.com Coopervision.com
Hello and Welcome!
This site is designed to help families learn more about myopia and how it can impact lives.

To proceed, please enter your age below:

By entering this site you are agreeing to the Terms of Use and Privacy Policy.